BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nialamide

An MAO inhibitor that is used as an antidepressive agent.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 42.3

Research Domains

Nialamide has been studied across 15 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, ❤️ Cardiovascular, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🌤️ Mood & Depression with 40% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nialamide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Tolazamide
9 shared targets
Sulfaphenazole
7 shared targets
Pinacidil
5 shared targets
Anastrozole
6 shared targets
Dexamethasone
6 shared targets
Lactic
5 shared targets
Torsemide
6 shared targets
Prednisone
7 shared targets
Chlormethiazole
4 shared targets
Nandrolone
5 shared targets
Loading evidence profile...

This evidence profile for Nialamide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.